ATMOSPHERE

Aliskiren Trial to Minimize OutcomeS in Patients with HEart failuRE

Henry Krum has been appointed as Study Chair of the ATMOSPHERE study which is being conducted at the Alfred Hospital and approximately 800 other sites throughout the world.  The aim is to recruit >7000 patients with systolic chronic heart failure to test the question of whether direct renin inhibition with the agent, aliskiren, is useful as add-on therapy to the gold standard agent (ACE-inhibitors) or may even be used as an alternative to these agents.